KPLBSEKwality Pharmaceuticals LtdMediumNeutral
Announced Mon, 30 Mar · 18:49 IST

outcome of postal ballot is attached herewith

Board & Shareholder Meetings View source PDF

KPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kwality Pharmaceuticals Limited announced the results of its postal ballot (notice dated February 21, 2026) for two special resolutions, both of which were passed with overwhelming majority. Resolution 1 approved the appointment of Mr. PreetMohinder Singh Bedi (DIN: 11452004) as Independent Director for 5 years, receiving 33,18,924 votes in favour (99.9996%) versus just 12 against. Resolution 2 approved the appointment of Mr. Bhavesh Mahajan (DIN: 09614108) as Independent Director for 5 years, with identical voting results. The e-voting was conducted via NSDL from February 27 to March 28, 2026. Promoter and promoter group voted 100% in favour of both resolutions. Scrutinizer Rishi Mittal & Associates confirmed the results on March 29, 2026.

Likely market impact

Both independent director appointments have been approved with near-unanimous support, strengthening board governance with no opposition from any shareholder group. This is a routine corporate governance matter with no direct impact on financials or stock price, though it reflects strong shareholder alignment with the board's recommendations.